Effect of dose escalation of rozrolimupab on platelet and hemoglobin concentrations. Platelet responses (A) and corresponding values of hemoglobin in individual patients (B) are shown. Continuous lines indicate patients treated without rescue medication; and dashed lines, patients who received rescue medication.